An interventional non-therapeutic study to assess ex vivo basophil activation in response to various preparations of taspoglutide and related items in blood samples from subjects who previously received taspoglutide and experienced a systemic allergic reactuin [Uno studio interventistico non terapeutico destinato a valutare l attivazione ex vivo dei basofili in risposta alle preparazioni di taspoglutide ed elementi correlati in campioni di sangue prelevati da soggetti che hanno ricevuto in precedenza taspoglutide e sperimentato una reazione allergica sistemica]

Trial Profile

An interventional non-therapeutic study to assess ex vivo basophil activation in response to various preparations of taspoglutide and related items in blood samples from subjects who previously received taspoglutide and experienced a systemic allergic reactuin [Uno studio interventistico non terapeutico destinato a valutare l attivazione ex vivo dei basofili in risposta alle preparazioni di taspoglutide ed elementi correlati in campioni di sangue prelevati da soggetti che hanno ricevuto in precedenza taspoglutide e sperimentato una reazione allergica sistemica]

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Sep 2013

At a glance

  • Drugs Taspoglutide (Primary)
  • Indications Diabetes mellitus
  • Focus Pharmacodynamics
  • Sponsors Ipsen
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 25 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top